Diet-induced obesity accelerates oral carcinogenesis by recruitment and functional enhancement of myeloid-derived suppressor cells.
Diet-induced obesity accelerates oral carcinogenesis by recruitment and functional enhancement of myeloid-derived suppressor cells.
复制标题
饮食引起的肥胖通过骨髓源性抑制细胞的募集和功能增强加速口腔癌的发生
DOI:
10.1038/s41419-021-04217-2
复制
发表时间:
2021-10-14
影响因子:
9
通讯作者:
Xia J
中科院分区:
文献类型:
--
作者:
Peng J;Hu Q;Chen X;Wang C;Zhang J;Ren X;Wang Y;Tao X;Li H;Song M;Cheng B;Wu T;Xia J
Although obesity has been associated with an increased risk and aggressiveness of many types of carcinoma, whether it promotes squamous cell carcinoma remains unclear. To reveal the role of obesity in oral squamous cell carcinoma (OSCC) initiation and development, we used 4NQO-induced OSCC model mice to examine the impact of dietary obesity on carcinogenesis. The results showed that high-fat diet (HFD)-induced obesity significantly promoted the incidence of OSCC and altered the local immune microenvironment with the expansion of CD11b+Gr1+myeloid-derived suppressor cells (MDSCs). The underlying mechanism that induced an immunosuppressive local microenvironment in obesity was the recruitment of MDSCs through the CCL9/CCR1 axis and enhancement of MDSC immunosuppressive function via intracellular fatty acid uptake. Furthermore, clinical samples verified the increase in infiltrated CD33+(a marker of human MDSCs) cells in obese OSCC patients, and data from the TCGA dataset confirmed that CD33 expression was positively correlated with local adipocytes in OSCC. Survival analysis showed that enrichment of adipocytes and high expression of CD33 were associated with poor prognosis in OSCC patients. Strikingly, depletion of MDSCs significantly ameliorated HFD-promoted carcinogenesis in 4NQO-induced model mice. These findings indicate that obesity is also an important risk factor for OSCC, and cancer immunotherapy, especially targeting MDSCs, may exhibit greater antitumor efficacy in obese patients.
登录
查看更多内容
DOI:
10.1158/1055-9965.epi-14-0709-t
发表时间:
2014-11
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
Etemadi A;O'Doherty MG;Freedman ND;Hollenbeck AR;Dawsey SM;Abnet CC
通讯作者:
Abnet CC
DOI:
10.1016/s1470-2045(18)30078-0
发表时间:
2018-03
期刊:
The Lancet. Oncology
影响因子:
--
作者:
McQuade JL;Daniel CR;Hess KR;Mak C;Wang DY;Rai RR;Park JJ;Haydu LE;Spencer C;Wongchenko M;Lane S;Lee DY;Kaper M;McKean M;Beckermann KE;Rubinstein SM;Rooney I;Musib L;Budha N;Hsu J;Nowicki TS;Avila A;Haas T;Puligandla M;Lee S;Fang S;Wargo JA;Gershenwald JE;Lee JE;Hwu P;Chapman PB;Sosman JA;Schadendorf D;Grob JJ;Flaherty KT;Walker D;Yan Y;McKenna E;Legos JJ;Carlino MS;Ribas A;Kirkwood JM;Long GV;Johnson DB;Menzies AM;Davies MA
通讯作者:
Davies MA
影响因子:
10.1
作者:
Hossain, Fokhrul;Al-Khami, Amir A.;Ochoa, Augusto C.
通讯作者:
Ochoa, Augusto C.
影响因子:
8.4
作者:
He, Jin-Yong;Wei, Xiao-Hui;Sun, Li
通讯作者:
Sun, Li
DOI:
10.1136/bmj.j477
发表时间:
2017-02-28
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Kyrgiou M;Kalliala I;Markozannes G;Gunter MJ;Paraskevaidis E;Gabra H;Martin-Hirsch P;Tsilidis KK
通讯作者:
Tsilidis KK